Abstract:Background: Schizophrenia (SCZ) and type 2 diabetes mellitus (T2D) are both complex diseases. Accumulated studies indicate that schizophrenia patients are prone to present the type 2 diabetes symptoms, but the potential mechanisms behind their association remain unknown. Here we explored the pathogenetic association between SCZ and T2D based on pathway analysis and protein-protein interaction.Results: With sets of prioritized susceptibility genes for SCZ and T2D, we identified significant pathways (with adjusted p-value < 0.05) specific for SCZ or T2D and for both diseases based on pathway enrichment analysis. We also constructed a network to explore the crosstalk among those significant pathways. Our results revealed that some pathways are shared by both SCZ and T2D diseases through a number of susceptibility genes. With 382 unique susceptibility proteins for SCZ and T2D, we further built a protein-protein interaction network by extracting their nearest interacting neighbours. Among 2,104 retrieved proteins, 364 of them were found simultaneously interacted with susceptibility proteins of both SCZ and T2D, and proposed as new candidate risk factors for both diseases. Literature mining supported the potential association of partial new candidate proteins with both SCZ and T2D. Moreover, some proteins were hub proteins with high connectivity and interacted with multiple proteins involved in both diseases, implying their pleiotropic effects for the pathogenic association. Some of these hub proteins are the components of our identified enriched pathways, including calcium signaling, g-secretase mediated ErbB4 signaling, adipocytokine signaling, insulin signaling, AKT signaling and type II diabetes mellitus pathways. Through the integration of multiple lines of information, we proposed that those signaling pathways, which contain susceptibility genes for both diseases, could be the key pathways to bridge SCZ and T2D. AKT could be one of the important shared components and may play a pivotal role to link both of the pathogenetic processes.Conclusions: Our study is the first network and pathway-based systematic analysis for SCZ and T2D, and provides the general pathway-based view of pathogenetic association between two diseases. Moreover, we identified a set of candidate genes potentially contributing to the linkage between these two diseases. This research offers new insights into the potential mechanisms underlying the co-occurrence of SCZ and T2D, and thus, could facilitate the inference of novel hypotheses for the co-morbidity of the two diseases. Some etiological factors that exert pleiotropic effects shared by the significant pathways of two diseases may have important implications for the diseases and could be therapeutic intervention targets.

A Hypothesis-Driven Pathway Analysis Reveals Myelin-Related Pathways That Contribute to the Risk of Schizophrenia and Bipolar Disorder.

Unraveling NEK4 As a Potential Drug Target in Schizophrenia and Bipolar I Disorder: A Proteomic and Genomic Approach.

Varying Mutational Classes Illuminate Differential Genetic Patterns Between Schizophrenia and Bipolar Disorder

Systematic genetic analyses of genome-wide association study data reveal an association between the key nucleosome remodeling and deacetylase complex and bipolar disorder development.

Two Gene Co-expression Modules Differentiate Psychotics and Controls

The genetics of schizophrenia: glutamate not dopamine?

Genome-Transcriptome-Functional Connectivity-Cognition Link Differentiates Schizophrenia from Bipolar Disorder

Comprehensive Pathway Analyses of Schizophrenia Risk Loci Point to Dysfunctional Postsynaptic Signaling

Pathway-wide Association Study Identifies Five Shared Pathways Associated with Schizophrenia in Three Ancestral Distinct Populations

Histone Acetylation and Methylation Underlie Oligodendroglial and Myelin Susceptibility in Schizophrenia

Exploring the Pathogenetic Association Between Schizophrenia and Type 2 Diabetes Mellitus Diseases Based on Pathway Analysis

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

Weighted Gene Coexpression Network Analysis Reveals Essential Genes and Pathways in Bipolar Disorder

Insights into myelin dysfunction in schizophrenia and bipolar disorder

Identifying novel proteins underlying bipolar disorder via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data

Dissecting the Association Between Psychiatric Disorders and Neurological Proteins: a Genetic Correlation and Two-Sample Bidirectional Mendelian Randomization Study.

Association of neurotransmitter pathway polygenic risk with specific symptom profiles in psychosis

Identification of Schizophrenia Related Biological Pathways Across Eight Brain Regions

Exploring shared genetic bases and causal relationships of schizophrenia and bipolar disorder with 28 cardiovascular and metabolic traits

Genetic associations between bipolar disorder and brain structural phenotypes

Novel Gene-Brain Structure Relationships in Psychotic Disorder Revealed Using Parallel Independent Component Analyses.